Epidemiology, Public Health, and Health Services Evaluation
ESPASS
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2020
-
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines
British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1034-1051